Genmab valuation
kr 3,502.00Change from previous close: −0.77%Absolute change: −kr 27.00
Valuation
The P/E ratio is 46.2. The average price target of 13 analysts is kr 4,195.23.
Data as of November 17, 2026
Genmab compared with similar companies
Genmab's P/E (trailing 12 months): 46.2, +16% against the median of a group of 10 similar companies (40.0).
| Metric | Genmab | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 46.2 | 40.0 | 15.7 – 55.4 | Middle |
| Forward P/E | 29.7 | 31.6 | 23.9 – 37.2 | Middle |
| EV/EBITDA | 167.2 | 27.3 | 18.1 – 63.0 | High |
| Price/book | 5.22 | 5.22 | 2.75 – 8.40 | Middle |
| Price/sales | 49.9 | 8.06 | 3.49 – 18.2 | High |
| Gross margin | 92.7% | 76.2% | 59.2% – 93.2% | Middle |
| Operating margin | 30.6% | 26.9% | 13.3% – 34.0% | Middle |
| Net margin | 17.0% | 19.9% | 12.3% – 28.5% | Middle |
| ROE | 12.1% | 12.1% | 6.0% – 19.6% | Middle |
| Debt/equity | 0.82 | 0.03 | 0.02 – 0.10 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- kr 214.45B
- Enterprise value
- kr 226.7B
- PEG
- 4.60
- EV/revenue
- 52.8
Profitability and growth
- ROA
- 8.2%
- ROIC
- 12.7%
- Revenue growth (year over year)
- 16.1%
- Earnings growth (year over year)
- -14.7%
Financial health
- Total cash
- kr 1.87B
- Total debt
- kr 5.2B
- Current ratio
- 2.45
- Quick ratio
- 2.43
- Altman Z-Score
- 3.02
- Piotroski F-Score
- 4.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- kr 4,195.23
- Median price target
- kr 4,415.00
- High price target
- kr 4,900.00
- Low price target
- kr 3,200.00
- Analysts with a price target
- 13
- Consensus
- Strong buy
- Forward EPS
- kr 117.07
- EPS estimate, current year
- kr 84.26
Shares and trading
- Beta
- 0.52
- Average volume
- 157.81K
- Shares outstanding
- 61.66M
- Float
- 58.91M
- Institutional ownership
- 46.4%
- Insider ownership
- 1.1%
